Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population

2015 ◽  
Vol 26 (12) ◽  
pp. 1806-1813.e1 ◽  
Author(s):  
Lisa M. Tom ◽  
Harold I. Palevsky ◽  
Douglas S. Holsclaw ◽  
Scott O. Trerotola ◽  
Mandeep Dagli ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Bronchial Artery ◽  
Adult Population ◽  
Recurrent Bleeding ◽  
Bronchial Artery Embolization ◽  
Artery Embolization

scholarly journals Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Jung Han Hwang ◽  
Jeong Ho Kim ◽  
Suyoung Park ◽  
Ki Hyun Lee ◽  
So Hyun Park
Keyword(s):  
Survival Rate ◽  
Bronchial Artery ◽  
Clinical Success ◽  
Massive Hemoptysis ◽  
Recurrent Bleeding ◽  
Recurrence Free Survival ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Free Survival

Abstract Purpose To evaluate the safety, efficacy, and long-term outcome of bronchial artery embolization (BAE) in the treatment of non-massive hemoptysis and the prognostic factors associated with recurrent bleeding. Materials and methods From March 2005 to September 2014, BAE was performed in 233 patients with non-massive hemoptysis. All patients had a history of persistent or recurrent hemoptysis despite conservative medical treatment. We assessed the technical and clinical success, recurrence, prognostic factors related to recurrent bleeding, recurrence-free survival rate, additional treatment, and major complications in all the patients. Results Technical success was achieved in 224 patients (96.1%), and clinical success was obtained in 219 (94.0%) of the 233 patients. In addition, 64 patients (27.5%) presented hemoptysis recurrence with median time of 197 days after embolization. Tuberculosis sequelae and presence of aberrant bronchial artery or non-bronchial systemic collaterals were significantly related to recurrent bleeding (p < 0.05). The use of Histoacryl-based embolic materials significantly reduced the recurrent bleeding rate (p < 0.05). Patient who had a tuberculosis sequelae showed a significantly lower recurrence-free survival rate (p = 0.013). Presence of aberrant bronchial artery or non-bronchial systemic collaterals showed a statistically significant correlation with recurrence-free survival rate (p = 0.021). No patients had major complications during follow-up. Conclusions BAE is a safe and effective treatment to manage non-massive hemoptysis. The procedure may offer a better long-term control of recurrent hemoptysis and quality of life than conservative therapy alone.

scholarly journals Clinical outcomes of cystic fibrosis patients with hemoptysis treated with bronchial artery embolization

2021 ◽  
pp. e20200557
Author(s):  
Marília Amaral Peixoto da Silveira1,2 ◽  
Patrícia Amaral Peixoto da Silveira3 ◽  
Flávia Gabe Beltrami1,2 ◽  
Leandro Armani Scaffaro4 ◽  
Paulo de Tarso Roth Dalcin1,2
Keyword(s):  
Cystic Fibrosis ◽  
Chronic Infection ◽  
Retrospective Cohort ◽  
Bronchial Artery ◽  
Massive Hemoptysis ◽  
Recurrent Bleeding ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Period 2 ◽  
Number Of Patients

Objective: Massive hemoptysis is one of the most serious complications in patients with cystic fibrosis (CF). This study aimed to evaluate the hemoptysis-free period following bronchial and non-bronchial artery embolization (BAE/non-BAE) in CF patients and to investigate predictors of recurrent bleeding and mortality by any cause. Methods: This was a retrospective cohort study of CF patients = 16 years of age undergoing BAE/non-BAE for hemoptysis between 2000 and 2017. Results: We analyzed 39 hemoptysis episodes treated with BAE/non-BAE in 17 CF patients. Hemoptysis recurrence rate was 56.4%. Of the sample as a whole, 3 (17.6%) were hemoptysis-free during the study period, 2 (11.8%) underwent lung transplantation, and 3 (17.6%) died. The median hemoptysis-free period was 17 months. The median hemoptysis-free period was longer in patients with chronic infection with Pseudomonas aeruginosa (31 months; 95% CI: 0.00-68.5) than in those without that type of infection (4 months; 95% CI: 1.8-6.2; p = 0.017). However, this association was considered weak, and its clinical significance was uncertain due to the small number of patients without that infection. Conclusions: BAE appears to be effective in the treatment of hemoptysis in patients with CF.

scholarly journals Bronchial carcinoid tumor managed with bronchial artery embolization before endobronchial resection: A case report

2021 ◽  
Author(s):  
Shigehisa Kajikawa ◽  
Kojiro Suzuki ◽  
Nozomu Matsunaga ◽  
Natsuki Taniguchi ◽  
Toyonori Tsuzuki ◽  
...  
Keyword(s):  
Case Report ◽  
Carcinoid Tumor ◽  
Bronchial Artery ◽  
Bronchial Carcinoid ◽  
Bronchial Artery Embolization ◽  
Artery Embolization

Control of Tubercular Haemoptysis by Bronchial Artery Embolization

1997 ◽  
Vol 27 (3) ◽  
pp. 149-150 ◽  
Author(s):  
Sanjeev Mani ◽  
Rajesh Mayekar ◽  
Ravi Rananavare ◽  
Deepti Maniar ◽  
J Mathews Joseph ◽  
...  
Keyword(s):  
Bronchial Artery ◽  
Bronchial Artery Embolization ◽  
Artery Embolization ◽  
Selective Embolization ◽  
Bronchial Arteries ◽  
Bleeding Vessel ◽  
Life Threatening ◽  
Abnormal Bleeding ◽  
Recurrent Haemoptysis

Thirty-seven patients presenting with massive or recurrent haemoptysis secondary to tuberculous aetiology were subjected to bronchial artery angiography. Of these, failure to catheterize the bleeding vessel occurred in two patients while embolization was withheld in two patients due to the presence of anterior spinal artery arising from a common intercosto-bronchial trunk. Immediate arrest of bleeding was performed in the remaining 33 patients by selective embolization of the abnormal bronchial arteries with a resorbable material (Gelfoam). Regular follow up for a duration of 6 months after the procedure revealed relapse of haemoptysis in four patients; three were treated by re-embolization of the abnormal bleeding vessels while one patient died due to aspiration immediately on admission. No recurrence of bleeding was seen in the remaining 29 patients. It is concluded that bronchial artery embolization is an effective treatment for immediate control of life-threatening haemoptysis.

Sign in / Sign up

Export Citation Format

Share Document